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Maternal-Fetal Medicine ( MFM ) is a subspecialty of Obstetrics and Gynecology that deals with various 
obstetrical, medical, and surgical complications of pregnancy.  Care is provided for both the mother and 
fetus in a complicated pregnancy.  The MFM specialist also provides education and research concerning the 
most recent approaches to the diagnosis and treatment of obstetrical problems.  This promotes societal 
awareness of the diagnostic and therapeutic techniques available for the optimal management of 
complicated pregnancies.  Less than 4% of obstetricians subspecialize in MFM.  The type of practice varies. 
In addition to caring for women with high risk pregnancies in regional high risk centers, MFM specialists 
serve as consultants to the midwives, family practitioners, and obstetricians who provide the majority of 
pregnancy care in the U.S. 
The sequence of the name Maternal-Fetal Medicine is deliberate.  Mothers are essential and the loss of a 
mother is a devastating tragedy.  Maternal mortality is the death of a woman while pregnant or within 42 
days after delivery.  The leading causes of death are blood loss, hypertensive disease, blood clots in major 
vessels, infection, and anesthetic accidents.  Reliable records on maternal deaths have only been available 
since the mid-19th century.  High maternal death rates were the rule until the 1930s when they began a 
rapid decline.  One hundred years ago the chance of dying from pregnancy related causes was 1 in 200. 
Currently the risk is closer to 1 in 10,000 in the developed world.  The persistent high risk of maternal death 
in the developing world is a glaring inequity,  In places like sub-Saharan Africa it is nearly the same as it 
was a century ago.  Most of the 500,000 mothers lost each year in the developing world could be saved by 
the provision of basic obstetric care. 
This is because the major determinant of maternal mortality is the overall standard of obstetrical care 
provided to the patient.  Poverty rates and nutrition have very little independent effect.  During the 19th 
century the upper classes were at higher risk for maternal death because they were more likely to be 
attended by physicians who sometimes used dangerous interventions.  (This historical fact should make 
those of us in medicine humble and should motivate us to be vigilant for similar dangers in modern medical 
practices.)  Even in developed countries, maternal mortality is often preventable.  Yearly surveillance of the 
rates on local, regional, national, and international levels provides information that can be used to prevent 
deaths in the future. A recent study of maternal mortality in Japan demonstrated what has been shown true 
elsewhere, that there is more danger when the same physician provides anesthetic and delivery care. 
As one of ten high risk pregnancy specialists in a busy practice I see a complicated referral population. The 
subspecialty of MFM is only two and one half decades old and is unique in that we care for two patients in 
the mother and her unborn child.  Sometimes our colleagues involved in the treatment of infertility are so 
successful that we have even more than two patients.  As outlined by others at this conference, this is a 
situation which presents its own array of ethical dilemmas.  Only on very rare occasions are the true medical 
interests of the mother and unborn baby in conflict. 
Progress in the area of obstetrics and maternal-fetal medicine has been astonishing. By the middle of the 
20th century obstetrics had made great strides in making pregnancy and birth a relatively safe experience 
for women.  Developments in antibiotics, transfusion and anesthesia decreased the risk of maternal death 
by 50-100 fold.  Attention was then turned to improving the outcome for the baby-our second patient.  Fetal 
monitoring was developed and some cases of fetal distress could be identified before and during labor.  This 
was generally beneficial but also led to many unnecessary cesarean sections, not the first or last time that 
the best of intentions has had negative consequences. 
During the late 1960’s and early 1970’s the development and use of Rh immune globulin  decreased the 
number of pregnancies complicated by Rh problems.  In those pregnancies where Rh incompatibility was 
present, fetal treatment was first used.  This was accomplished by prenatal transfusion of blood into the 
abdominal cavity of affected fetal humans.  The new focus on the baby was achieved by development of 
fetal ultrasound imaging technology.  Prior to obstetrical ultrasound the anatomic development and activities 
of the fetus were invisible. 
The developer of prenatal ultrasound, Professor Ian Donald of Scotland, served in the British Navy during 
World War II and became familiar with the use of sonar to detect submarines.  By the 1960’s he had 
developed exciting but unrefined methods of using sound waves to look into the uterus.  During the 1970’s 
and 80’s the beneficial uses of ultrasound in pregnancy multiplied as the technology was improved.  Today 
the practice of modern obstetrics would be impossible without ultrasound and nearly everyone has seen 
ultrasound images of babies before birth. 
Current ultrasound imaging techniques reveal the marvelous complexity of prenatal growth and 
development.  Just as parents of newborns mark their baby’s developmental progress with activity 
milestones, thanks to ultrasound technology we can see similar developmental milestones for unborn babies. 
However the use of this wonderful window on the womb has become increasingly disconcerting for those 
who are willing to accord fetal humans only tentative and conditional protection. 
Internet access to the National Library of Medicine by way of the Grateful Med program is one of the benefits 
of practicing medicine in the 21st Century. It is important to mention the times when government programs 
are an unqualified success.  In only minutes one can do a comprehensive search of any combination of 
medical topics referencing thousands of medical journals published during the last thirty years. It is 
instructive to do a literature search covering the topic of treatment of babies before birth. 
In the last two and one half decades three factors, rapid developments in genetics, ultrasound technology, 
and the increasing availability of fetal treatment options have expanded the concept of the fetus as a 
patient.  Over that time the number of studies describing the fetus as a patient has multiplied.  Between 
1966-74 there were none, from 1975-1979 there were a few dozen, between 1980-1984 there were a 
couple of hundred.  Over the last 16 years there have been thousands of articles describing the various ways 
that prenatal diseases can be detected and, increasingly, treated.  There are also now numerous texts 
specifically addressing the fetus as a patient. 
Fetuses can be treated with medications for dangerously irregular heart rhythms and heart failure.  They can 
receive red blood cell or platelet transfusions if they are anemic or lacking in platelets.  On rare occasions 
surgical procedures can be performed before birth.  A frequent use of ultrasound is to evaluate the health of 
our unborn patients.  In high risk situations we recommend frequent ultrasound “checkups” that look for 
prenatal breathing movements, other motor activities, and resistance to blood flow in the placenta.  Normal 
findings on these tests suggest that the risk of stillbirth is low. 
Fetal treatment centers have done basic and applied research on fetal medical and surgical treatment.  One 
of the most dangerous abnormalities of fetal development in identical twins is the twin-twin transfusion 
syndrome.  In this situation a vascular connection in the placenta allows transfer of blood leaving one twin 
anemic and the other overloaded.  This problem can be diagnosed by prenatal ultrasound and pioneering 
groups perform in utero laser treatments to interrupt the interconnections.  This has improved the outcome 
for some affected babies.  Promising, though controversial, recent work has also been done with in-utero 
repair of neural tube defects such as spina bifida. These pioneers in prenatal surgery have found that fetal 
skin wounds heal without significant scarring.  We are clearly in a new era of obstetrics because of 
ultrasound and the expanding concept of the treatment of the fetus as a patient.  But the tragedy is that 
modern medicine works within a legal environment which says that a fetus is a patient only when the 
mother has conferred this status.  The trouble is that this status can be withheld or withdrawn. 
Another major component of MFM practice is prenatal diagnosis.  This is the use of screening and 
subsequent targeted techniques to assess the anatomy and genetic makeup of the fetus.  These range from 
maternal serum tests for various biochemical substances that can identify women at increased risk for fetal 
abnormalities, through detailed ultrasound studies, to invasive techniques that directly sample fetal cells. 
Its use in the U.S. has expanded dramatically, although some commentators suggest that modern obstetrics 
is becoming an impersonal technospecialty dedicated to delivering “the perfect baby”.  Prenatal diagnosis 
can benefit the mother and baby when treatment options are available, but much of prenatal diagnosis is 
designed to detect fetal abnormalities so that the choice of abortion is available.  But what fits the definition 
of an abnormality?  Even abortion supporters are horrified by the possibility of abortions based only on the 
sex of the unborn child. But is abortion for the most sexist of reasons any worse than abortion for any other 
reason? 
Despite claims that the abortion question has been settled, the ongoing debate over the morality of abortion 
complicates the practice of MFM.  The premise of an unrestricted right to abortion dictates that a fetus is 
only conditionally a patient.  Pending further developments in fetal treatment the major management option 
after prenatal diagnosis is what has been inaccurately termed “therapeutic abortion”.  The abnormalities 
which are “treated” by abortion range from lethal defects such as anencephaly, through often nonlethal 
defects such as trisomy 21, to correctable defects such as cleft lip and palate.  At present between 50 and 
80 percent of women carrying fetuses with various abnormalities are choosing abortion.  It is debatable 
whether these decisions are made with truly informed consent. 
Interdisciplinary studies are a benefit of participation in a University.  The insights and expertise of 
specialists in areas other than my own gives a fresh perspective to my daily practice activities.  Without new 
insights it is easy to grind on with the routine, missing the chance to improve my abilities so that I can 
better meet the needs of my patients.  When following the trends in medical literature one can be taken by 
surprise.  The application of cost/benefit analyses to prenatal diagnosis was an eye-opener for me.  An 
important but disturbing article was published in the April 2000 issue of the American Journal of Medical 
Genetics.  It uses estimated lifetime costs of various prenatally diagnosable problems to argue against any 
restriction of abortion following prenatal diagnosis.  A copy of the article is available.  I commend it to you 
for your reading and analysis. 
Based on the current practice of MFM we are certainly offering and encouraging individual and family-based 
eugenics.  Though we do not yet have an overt eugenic social policy there are an increasing number of 
articles using cost/benefit analyses to defend unrestricted abortion or to promote and encourage prenatal 
diagnosis (with abortion as the implicit “treatment option”). When argued for on this basis might we expect 
that individual pregnant women could eventually be pressured to submit to prenatal diagnosis for the social 
and fiscal health of society?  Has the society become the patient on the basis of economic calculations? 
The most frequently articulated defense of a right to abortion has been made on the basis of autonomy. This 
means that the decision to end or continue a pregnancy, whether or not the fetus is affected by an 
abnormality, is based on an individual decision by a woman using her own assessment of her situation, in 
consultation with her physician.  The patient/physician relationship has also always been a personal one. 
But is that changing?  Traditionally the primary role of the physician has been that of healer and counselor 
to the individual patient.  There are obviously times when public health considerations are important, yet the 
duty to the individual patient takes precedence.  There is great danger when physicians become agents for 
the state or when individual physicians subordinate their patient’s best interest to what the physician 
believes are the best interests of society.  I believe that we are currently on treacherous footing in this 
regard. Should cost/benefit analyses be applied to prenatal diagnosis when the most frequent intervention is 
abortion of the fetus? 
Besides the starkly sinister effect of depriving preborn humans of life based on their anatomy or physiology 
there is another reason to oppose this practice. Making financial arguments for prenatal diagnosis/abortion 
ignores the unquantifiable commodity of human potential.  Disability is a relative term and there is little 
correlation between the presence of a problem and what individual human beings can accomplish. According 
to what has been called “the disability rights critique”  raised by advocates for the disabled, prenatal 
diagnosis of congenital anomalies followed by abortion is based on inaccurate information regarding living 
with disabilities. It is also claimed that this will weaken society’s commitment to the inclusion and care of the 
disabled in our human community.  A special supplement to the Hastings Center Report ( Sept-Oct 1999 ) is 
an excellent summary of this critique. 
As the human genome is laid open like a book we will all likely find genetic time bombs ticking away in our 
chromosomes - perhaps the near certainty of Alzheimer’s Disease or a strong likelihood of cancer.  To the 
degree that this information is used to develop prevention or treatment strategies it will be a benefit, but to 
the degree that it is used like current prenatal diagnosis it will be a threat to human freedom and potential. 
In medical school, physicians are taught that signs of serious illness in our patients are often subtle.  On a 
larger scale, the beginning of an epidemic can be detected by identification of a small number of early cases. 
These principles of good medical practice should be applicable to signs of a dangerous moral pathology, 
even when the disease arises within the medical profession itself.   Will doctors be alarmed by the 
application of cost/benefit analyses in these ways?  We shall see.  In the crucial area of  moral judgment, 
modern medical education can anesthetize its students.  Hopefully the level of moral anesthesia induced is 
not too deep or widespread. 
The disabled community suggests that the rest of society should be known as the “temporarily abled”.  This 
is because disability can be acquired as well as inherited.  It can be in your genes or it can come in the 
aftermath of an automobile accident. It can affect any one of us. Therefore we should be vigilant for trends 
such as this that place a value on persons by calculating what they will cost society.  That is a path that was 
trod only too recently and it darkened the middle of the last century.  We should have the wisdom and moral 
courage to refuse to go that direction again. 
In the United States we are dealing with the medical, social, and political fallout of our Supreme Court’s 
willingness to erase the traditional boundaries of medical ethics and practice.  The tenets of Hippocratic 
medicine have served us well for more than 2,000 years.  Our 27 year experiment with unrestricted abortion 
has caused the practice of medicine to become increasingly inconsistent.  The tension between valuable 
protective ethical traditions and currently legal medical practice is untenable.  Using cost/benefit analyses to 
argue for prenatal diagnosis and abortion cannot factor in the loss of individual human potential nor can it 
avoid the erosive effect that abortion for traits or characteristics will have on society’s commitment to the 
disabled.  The outlook for MFM practice in the future should resemble a promising sunrise, but there are 
some very ominous clouds forming on the horizon. 
 
 
